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Voltage gated potassium channels (KV) are membrane proteins that allow selective flow of
K+ ions in a voltage-dependent manner. These channels play an important role in several
excitable cells as neurons, cardiomyocytes, and vascular smooth muscle. Over the last
20 years, it has been shown that omega-3 polyunsaturated fatty acids (PUFAs) enhance
or decrease the activity of several cardiac KV channels. PUFAs-dependent modulation
of potassium ion channels has been reported to be cardioprotective. However, the
precise cellular mechanism underlying the cardiovascular benefits remained unclear in
part because new PUFAs targets and signaling pathways continue being discovered.
In this review, we will focus on recent data available concerning the following aspects
of the KV channel modulation by PUFAs: (i) the exact residues involved in PUFAs-KV
channels interaction; (ii) the structural PUFAs determinants important for their effects on
KV channels; (iii) the mechanism of the gating modulation of KV channels and, finally,
(iv) the PUFAs modulation of a few new targets present in smooth muscle cells (SMC),
KCa1.1, K2P, and KATP channels, involved in vascular relaxation.
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INTRODUCTION
It has been reported that an increased consumption of omega 3 polyunsaturated fatty acids (n-3
PUFAs; Figure 1) have beneficial properties for the cardiovascular system (Chaddha and Eagle,
2015) and neurological diseases such as epilepsy and pain (Lefevre and Aronson, 2000). Among
other targets, the beneficial actions of n-3 PUFAs occur through the modulation of a big variety of
K+ voltage gated ion channels (Boland and Drzewiecki, 2008; Moreno et al., 2012). For instance, it
is known that n-3 PUFAs activate different members of the KV7 channel family. In the heart, n-3
PUFAdependent activation of KV7.1 channels (pore forming component of the cardiac IKs) reduces
the risk of arrhythmia by shortening the action potential duration (Verkerk et al., 2006; Liin et al.,
2015; Moreno et al., 2015). In the neuronal system, the activation of KV7.2/KV7.3 channels (major
components of the neuronal M-current) decreases neuronal excitability and therefore the risk of
seizure (Liin et al., 2016; Valenzuela, 2016).
Despite the encouraging results of the first clinical trials published in the early 2000s about
n-3 PUFAs protective effects, very soon other studies reported no beneficial or even harmful
effects. For example, an increased risk of cardiac events was found in angina pectoris patients
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FIGURE 1 | Chemical structures of representative fatty acids (monounsaturated: n-9 MUFA, n-3, and n-6 PUFAs) and modified PUFAs (DHA-ethyl-ester
DHA and DHA-amine: non-charged and permanently charged, respectively).
(Burr et al., 2003). The physiological effects of PUFAs are
complex and poorly understood. In the context of excitable
diseases, we believe that the conflicting results emerged from
the lack of exhaustive knowledge on two aspects of the n-
3 PUFA-dependent modulation of voltage-gated ion channels.
The mechanisms by which n-3 PUFAs differentially modulate
ion channels and for which specific pathologies n-3 PUFAs are
truly beneficial are poorly understood. Different cardiovascular
and neuronal pathologies are triggered by different underlying
mechanism. Therefore, a diet rich in n-3 PUFAs might be
beneficial for some conditions but neutral or deleterious for
others.
Themechanism of action by which PUFAsmodify ion channel
activity has been debated for years. Several theories, ranging from
(1) non-specific effects on the cell membrane (Leifert et al., 1999)
to (2) specific binding to the ion channel (Hallaq et al., 1992;
Kang and Leaf, 1996; Bendahhou et al., 1997; Xiao et al., 2005;
Guizy et al., 2008), have been proposed. Scientific evidence in
favor of the indirect modulation of ion channels by n-3 PUFAs
are the lack of selectivity in blocking a given channel vs. other, and
the reported effects on the cell membrane fluidity. On the other
hand, the identification of residues in the ion channel protein
involved in n-3 PUFAs sensitivity argues in favor of the second
theory. A great step forward defining the molecular mechanism
of n-3 PUFAs modulation of KV channels has been recently
achieved. The identification of the PUFA binding site on several
K+ channels, the proposed mechanism of action for the direct
effects of PUFAs and the experimental evidence showing that n-3
PUFAs can modify the gating of ion channels simultaneously by
establishing direct interactions and by modifying the properties
of the lipid bilayer were essential findings that helped to clear up
the controversy (Borjesson et al., 2008; Moreno et al., 2015).
Important advances have been achieved in the identification
of the specific pathologies that could benefit from a diet rich on
n-3 PUFAs as well. In this regard, many new ion channel targets
in different organs and tissues have been identified, and disease
animal models have been produced to understand how PUFAs
can affect physiology.
In the present review we first summarize results identifying
the PUFA binding site on K+ ion channels, the molecular
determinants that determine the affinity and potency within the
n-3 PUFA molecule, and the proposed mechanism of action
by which n-3 PUFAs modify the gating K+ channels: the
“lipoelectric hypothesis.” In the second part of the review, we
focus on recent findings in PUFAs-dependent modulation of the
KV7 family and a few new targets: K2P, KCa1.1, and KATP in the
cardiovascular and neuronal function. Finally, we briefly discuss
how the PUFAs represent a new pharmacological treatment in
which ion channel voltage dependence is electrically modulated
instead of the more traditional pore block.
SELECTIVE PUFA EFFECTS ON
DIFFERENT POTASSIUM CHANNELS
In this section we recapitulate the arguments in favor of specific
PUFA-ion channel interactions emphasizing findings published
in last 5 years. We will focus on two potassium channels Shaker
and KCa1.1, for which the PUFA induced modulation of ion
channels, has been more extensively characterized.
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Evidences for Selective PUFAs Effects on
Shaker K+ Channels
After the initial studies based on the introduction of point
mutations in the ion channel to demonstrate point direct
interaction between the ion channel and the PUFA (Xiao et al.,
2001a,b), another solid evidence showing how PUFAs differently
modify ion channels raised from the observation that the potency
of the n-3 PUFA docosahexaenoic acid (DHA) on Shaker voltage
dependence changes with local pH (Borjesson et al., 2008). At
physiological pH, DHA increased Shaker K+ current by shifting
the midpoint of activation [G(V) curve] toward hyperpolarized
potentials. It is known that different ion channels have different
local pH values depending on their local set of surface charges
structure (Elinder et al., 1996). To explore the influence of the
surface charges and local pH on Shaker modulation by DHA,
Borjesson and colleagues used a mutated Shaker channel where
residues A419, F425, and V451 were made positive (Borjesson
et al., 2008). The presence of these three positive residues in
the extracellular loops connecting transmembrane segments S5
and S6 of Shaker K+ channels resulted in a local pH change
of 0.3. Under these conditions, DHA induced a negative shift
of the midpoint of activation in the triple mutant about twice
as large as the shift induced in the WT Shaker K+ channel.
These results clearly indicate that the PUFA-induced effect is
channel specific and depends on the channel-specific set of
surface charges (Borjesson et al., 2008).
The ultimate proof for the specific PUFAs effects on different
ion channels came with the identification of the PUFAs binding
site on Shaker channels. Because of its lipophilic character and
modulatory effects it was proposed that the PUFAs binding site
on Shaker K+ channels should be in the vicinity of the gating
charges in the voltage sensor (S4 segment) and near residues
facing the lipid bilayer (Borjesson et al., 2008). The confirmation
for the proposed binding site came quickly. A cysteine scan
analysis covering the lipophilic surfaces of the extracellular halves
of S3–S6 segment showed that residues I325C and T329C located
in the carboxyl end of helix S3, and I360C at S4 were insensitive
to DHA. On the contrary, the L366C mutation increased DHA
sensitivity of Shaker K+ channels (Borjesson and Elinder, 2011).
To further define the PUFAs binding site, positives charges were
introduced to each of the above-mentioned residues in the S3–
S4 regions by using MTSEA+ reagent. Consistently with the
cysteine scan data, a positive charge at residues I325; T329
and A359; I360 of the S3 and S4 respectively resulted in an
increased sensitivity to DHA effects (Borjesson and Elinder,
2011). In addition to the experimental data, a structural model
built to predict 3D interactions suggested that a negative charge
at R1 (R362) would reduce the PUFA effect. Consistently with
the model, when the charge of R362C mutant was modified
negatively with MTES− reagent the G(V) shift induced by DHA
was smaller than that induced in WT Shaker K+ channels.
In contrast, R362C+ (exposed to MTSET+) restored PUFA
sensitivity. Some KV channels such as KV1.2 have an additional
gating charge R0 at the top of the S4 segment. An homology
model of the Shaker K+ channel based on the KV1.2/2.1 chimera
predicts that a positive residue at that position (A359) could
strengthen the interaction between the PUFA head group and
the ion channel (Borjesson and Elinder, 2011). When attaching
MTSET+ to A359C, the DHA-induced G(V) shift was greater.
Experiments in which the charge of R0 and R1 was changed
support the proposed localization of the PUFA binding site and
suggested that different PUFAs should have very different effects
in modulating different ion channels depending on the presence
of a charge at positions R0 and/or R1 (Borjesson and Elinder,
2011). Together, the data showed that high impact residues for
DHA on Shaker K+ channels are clustered in a small region of
the lipid facing S3–S4 corner of the voltage sensor domain but
distant from the pore region (Figure 2). Positive charges located
close to the PUFAs binding site increase PUFA potency.
As shown for Shaker K+ channels, it has been reported
that PUFAs target the voltage sensor domain of many other
KV channels such as KV7.1 channels (Liin et al., 2015). In
KV7.1 channels, PUFAs interact with extracellular positively
charged residues of the S4 segment to promote channel opening.
Neutralization of the most external gating charge (R1) of the
S4 of KV7.1 channels, R228Q, made KV7.1 channels insensitive
to DHA, to DHA-glycine (a permanently deprotonated DHA
FIGURE 2 | Topology of a canonical voltage gated ion channel subunit
on the lipid bilayer and cartoon representation of the lipoelectric
hypothesis mechanism of PUFA-dependent modulation of Shaker-like
K+ channels. On the cell membrane four subunits co-assemble to for the ion
channel. (A) Each subunit contains six transmembrane segments and N-and
C-terminal domains. S1–S4 segments form the voltage sensor and S5–S6
form the ion pore. The S4 segment contains a variable number of positively
charged residues known as gating charges that detect small changes on the
electric field on the membrane. In response to prolong depolarizations the S4
moves upward perpendicular to the membrane and rotates. (B) This process
is called voltage sensor domain activation and it is indicated by the white
arrow. Once the four individual S4 are on the upstate the activation gate
located at the base intracellular site of the pore domain can open to allow K+
flow (red arrow). A simplified PUFA structure is depicted with the head group
located at the extracellular bilayer interface and the bilayer center is depicted in
yellow. The PUFA head group interacts electrostatically with the upper gating
charges of the S4 promoting mainly channel opening (red arrow). Top and
bottom right panels show the front view of the S5 and S6 segments in the
closed and open state. Two subunits are depicted for simplicity.
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analog at physiological pH due to its lower pKa value) and to
N-arachidonoyl taurine (with a permanent negative charge at
pH = 7.4). Besides the S4 gating charge residues, other amino
acids located in the outer halves of S3 and S4 had a big impact
in the PUFA modulatory effect. Again a cysteine scan analysis
showed that residues K218C and G219C, located in the S3–S4
extracellular linker of KV7.1 reduced the PUFA effect by a factor
of 3, suggesting the existence of PUFA binding site equivalent in
other KV channels (Liin et al., 2015).
Evidences for Selective PUFAs Effects in
hKCa1.1 Channels
Although in general different potassium channels show high
similarity regarding structural domains and gating mechanisms,
some important differences exist between different KV families.
One proof of that is the different location of the PUFA binding
site on different KV families as demonstrated for hKCa1.1
channels (or large conductance Ca2+- activated K+ channels).
In a study by Hoshi and colleagues it was shown that DHA
increased hKCa1.1 channels by 2.5-fold and induced a shift
of the G(V) curve into the negative direction (Hoshi et al.,
2013c). Regardless the potentiating effects of DHA on hKCa1.1
channels KCa1.1 channels from Drosophila were insensitive
to DHA. In order to determine the molecular determinants
within hKCa1.1 channels critical for the stimulatory effect,
chimeric constructions of Human/Drosophila hKCa1.1 channels
were done. The chimeric constructions revealed that the PUFA
binding site is located in the pore domain (S5, P-loop and S6
segments) of hKCa1.1 channels. Furthermore, the introduction
of Human-to-Drosophila point mutations in the pore domain of
hKCa1.1 highlighted the residue Y318S (located in the ion pore)
as a crucial determinant of the differential sensitivity of hKCa1.1
channels compared to dKCa1.1 to PUFAs (Hoshi et al., 2013c).
Besides the identification of the PUFA binding site in KCa1.1
channels, additional evidence in favor of a selective action of
PUFAs in hKCa1.1 channels raises from the different potency
shown by the fatty acids in hKCa1.1 channels co-expressed
with different modulatory subunits. In different tissues, hKCa1.1
channels are co-assembled with β1, β2, β4, or ϒ subunits
(Wu and Marx, 2010). Another study performed by Hoshi
and colleagues, showed a 2.5-fold current density increase
induced by DHA on hKCa1.1 channels (expressed in the absence
of modulatory subunits), while it increased hKCa1.1+β1 and
hKCa1.1+β4 by up to 20-fold and shifted the G(V) by −60 mV.
On the contrary, DHA was much less effective in hKCa1.1+β2
and hKCa1.1+ϒ1 channels (Figure 3). These differential effects
are very noteworthy because all β subunits share a similar amino
acid sequence and structural organization. Chimeric experiments
determined that the N-terminus and the first transmembrane
domain of β1 and β4 subunits are crucial for DHA sensitivity.
Finally, point mutations experiments in which amino acids in
β1 or β4 were substituted with that in β2 at the corresponding
location revealed that R11/E12 and C18/R19 are crucial for
DHA sensitivity in β1/β4 respectively. In addition, β2–β1 or
β4 substitutions at the equivalent positions were made which
showed indistinguishable sensitivity to DHA compared to β1 and
FIGURE 3 | Effects of DHA on KCa1.1 channels. (A) Chemical structure of
DHA. (B) Currents generated by KCa1.1, KCa1.1+β1, and KCa1.1+β4
channels in inside-out patches recorded in the absence of calcium. Current
records under control conditions and after addition of DHA (3 µM) are shown
in blue and red, respectively. (C) Current-voltage relationships obtained from
KCa1.1+β1 and KCa1.1+β4 are shown. Again, results from control and DHA
are shown in blue and red, respectively. Hoshi et al. (2013a)
β4 subunits (Hoshi et al., 2013a). All these results may suggest
that PUFAs binding site resides in both the α and in the β1 and
β4 subunits of the hKCa1.1 ion channel complex.
PUFAS STRUCTURAL DETERMINANTS
IMPORTANT FOR THEIR EFFECTS ON ION
CHANNELS
In parallel to the progression in the understanding of the
molecular determinants within the ion channels involved in
interactions with PUFAs, several publications have contributed
to the identification of the features within the PUFAs molecules
important for their effects. The PUFA molecule consists of an
aliphatic chain (of variable length) with two or more double
bonds capped at the end with a negatively charged carboxyl
group. Which are the crucial features for the modulation of K+
channels?
The Charge of the Carboxyl Group is
Crucial for the Electrostatic Interaction
with the Voltage Sensing Domain of the Ion
Channel
PUFAs such as DHA and arachidonic acid (AA) are negatively
charged at physiological pH 7.4. In order to test the effect
of the charge of the carboxyl group, Borjesson et al. (2008)
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compared the effects of DHA (negatively charged), DHA methyl
ester (non-charged transesterified DHA), and a charged lipolytic
toxin GsMTx4+ (structurally similar to PUFAs but with four
positive charges) on Shaker channels. DHA shifted the G(V)
curve by 10 mV toward the negative potentials. DHA methyl
ester had no effect on the voltage dependence. Conversely, the
GsMTx4+ toxin shifted the G(V) curve 5.7 mV into the positive
direction. In the same line of evidence it was shown that the
potency of DHA changes with pH. A higher pH potentiates DHA
effects because a larger fraction of the PUFA is deprotonated
(Borjesson et al., 2008). In another study, the pH-dependence
of the modulation of Shaker by arachidonoyl amine (AA+) was
analyzed (Borjesson et al., 2010). AA+ shifted the G(V) curve of
Shaker K+ channels toward positive potentials and decreased the
maximum conductance. AAmethyl ester had no effect. Following
a similar reasoning, if there is a pH-dependence for the amine
effect AA+ should be more effective at low pH. As expected, AA+
was more potent at a lower pH when a larger fraction of AA+ is
protonated (Borjesson et al., 2010).
The importance of a negative charge on the head group of
DHA is applicable to many other PUFAs but also to many other
potassium channels. In a recent study by Liin et al. (2015), it was
shown that DHA (negatively charged) shifted the G(V) by ∼ −9
mV of KV7.1 channels. On the contrary, DHA+ and AA+ shifted
the G(V) by ∼ +9 mV. Together, these results demonstrate
that the modulation of the voltage dependence of activation of
K+ channels toward hyperpolarized or depolarized potentials is
determined by the valence of the charge in the carboxyl head
group. A negative charge shifts the G(V) curve toward more
negative potentials and vice versa.
Two or More Cis Double Bonds in the Acyl
Chain are Necessary to Shift G(V) Curve
Borjesson and colleagues tested ten fatty acids or fatty acid-
like compounds with different acyl chain lengths and different
numbers, position, and geometry of double bonds to identify
structural features on the acyl tail important for the PUFA
modulation of Shaker K+ channels. Fatty acids with the most
structural similarity to DHA by having two or more methylene-
interrupted double bonds at either the n-3 or the n-6 position
showed similar shifts of the G(V) curves in Shaker channels
(Borjesson et al., 2008). The rest of the compounds were not
effective.
Recently, Yazdi et al. (2016) studied how the saturation levels
in the carbon tail affect the structure of the lipids in 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane
patches. From their molecular dynamics simulations the
following conclusions were extracted: (i) the order parameters of
PUFA and saturated fatty acids decreased from the carboxyl end
located in the bilayer interface to the end of the acyl chain tail in
the bilayer center. (ii) The order parameters displayed a different
overall shape reflecting the positions of the cis double-bonds
of PUFAs. (iii) There are differences in the shape and packing
properties by measuring the radius of gyration of the carbon tail
and head-to-tail length. Compared to other fatty acids, the PUFA
molecule tends to twirl and curl up. All together, these results
indicate that the PUFA molecule has greater conformational
mobility compared to saturated fatty acids. The predominant
saturated fatty acid conformation is more extended resulting in
a decreased flexibility and mobility of phospholipids of the cell
membrane (Yazdi et al., 2016).
Effect of the n-3 PUFA Acyl Chain Length
Contrary to the importance of a negatively charged carboxyl
group for the PUFA effect and the presence of two or more
double bonds, the impact of the length of the acyl tail for the
PUFAs effects is not so obvious. In Shaker K+ channels the
presence of two or more double bonds and its location in cis
geometry (more flexible) seem to be more important than the
number of carbons of the tail for the PUFA induced G(V) shift
(Borjesson et al., 2008). Similar findings were shown by Liin
et al. in KV7.1 channels (Liin et al., 2015). Two fatty acids: EPA
and oleic acid (OA), poly- and mono-unsaturated fatty acids
respectively with similar acyl tail length showed very different
effects on KV7.1 currents. OA had no effect on KV7.1 currents
while EPA showed a similar potency increasing KV7.1 compared
to DHA (Liin et al., 2015). On the other hand, a study by Hoshi
et al. (2013c) in which the effects of three n-3 PUFAs: DHA, EPA
and α-linolenic acid (ALA) were examined in hKCa1.1 channels
revealed that DHA had the largest stimulatory effect on hKCa1.1
currents followed by EPA and finally ALA. These results suggest
the importance of the length of the acyl might be channel specific
and that the longer the acyl tail, the larger the effect of the
PUFA will be.
MECHANISM OF GATING MODULATION:
LIPOELECTRIC HYPOTHESIS
Origin of the Lipoelectric Hypothesis and
Definition
Based on the following effects of DHA on Shaker K+ channels:
(i) shift of the G(V) and of the steady state inactivation
curve to the negative direction, and (ii) acceleration of the
activation kinetics and slower deactivation kinetics; Borjesson
and colleagues formulated in 2008 the “Lipoelectric hypothesis”
to explain the PUFAs-dependent modulation of K+ channels
mechanism. All these findings are in agreement with DHA and
other PUFAs causing electrostatic effect on the voltage sensor of
ion channels (Borjesson et al., 2008). The lipoelectric hypothesis
proposes that the lipophilic PUFAs bind to a hydrophobic
environment (the lipid bilayer or bilayer/channel interface close
to the S3-S4 segment) from where they act electrostatically on
the voltage sensor changing the voltage dependence of the ion
channel (Borjesson et al., 2008).
Which Activation Steps are Affected by
PUFAs?
It is known that the activation of Shaker K+ channels occur
in at least two steps. In the early transitions the four Shaker
subunits go through transitions between the closed states (C0 to
C2) and, then the channel goes through other two transitions to
the final closed and the open states (C2 to O). The transitions
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between the first closed states are sequential and represent
the activation of the voltage sensor, whereas those between
C2 to O are concerted and couple the movement of the
main voltage sensors to channel opening (Schoppa et al., 1992;
Bezanilla et al., 1994; Zagotta et al., 1994; Schoppa and Sigworth,
1998).
α0 α1 α1 α1 α2 α3 α4
C0↔ C1↔ C11↔ C12↔ C2↔ C3↔ C4↔ O
β0 β1 β1 β1 β2 β3 β4
To explore which activation step is affected by DHA, gating
currents were measured in two mutated Shaker K+ channel
constructions. The final transitions (from close C2 to open
O) were studied in the ILT mutant Shaker channel where
three hydrophobic residues in S4 are substituted for three
other hydrophobic residues (V369I, I372L, and S376T). In the
ILT mutant the voltage sensor activation and pore domain
opening steps are energetically separated allowing the study of
the late transitions during the channel activation in isolation
The initial steps of activation (C0 to C2) were studied in
the non-conducting channel resulting from the ILT mutant
plus the pore mutation W343F. DHA significantly shifted the
G(V) curve in the negative direction along the voltage axis.
On the contrary, DHA had a much smaller effect on the
gating currents Q(V) of the ILT/W343F Shaker mutant. The
larger effect of DHA seen on the G(V) compared to the
Q(V) curve suggests that the opening step (the second gating
component) is more affected than the early transition by the
PUFA (Borjesson et al., 2008). Despite DHA had a much smaller
effect on the gating currents, this small effect indicates that
the activation of independent voltage sensors is also affected. A
gating model of Shaker K+ channels predicted a DHA-dependent
shift of 30 and 5 mV in the G(V) and Q(V) respectively
corroborating the experimental data (Borjesson and Elinder,
2011).
PUFA Head Group is Closer to Shaker K+
Channel in the Open State
PUFAs interaction sites in the open and closed state were
determined by steered molecular dynamics simulations of Shaker
K+ channels in POPC bilayers (Yazdi et al., 2016). PUFAs
form clusters around the voltage sensor domain regions (VSD)
rather than the pore helices S5–S6. In general, significantly
higher contact frequencies were identified between the PUFA
and the protein in the open state. PUFA acyl tail-ion channel
protein contacts are predominantly non-specific: hydrophobic
and distributed across the VSD. PUFA heads-protein interactions
are more frequent in the open vs. closed state and are more
specific: hydrogen bonds between charged or polar residues of
the extracellular halves of S3 and S4 and PUFA head groups.
Saturated fatty acids established significantly fewer interactions
in closed vs. open state simulations and fewer contacts in the open
state compared to PUFAs. In summary, specific protein residues
involved in PUFAs vs. saturated fatty acids interactions are largely
different. While PUFAs establish predominantly contacts with
S3–S4 residues, there is a shift to the S1–S2 in saturated fatty acids
(Yazdi et al., 2016).
Place Dependence and Rotation of the
First Gating Charge R1 for the PUFA Effect
According to the lipoelectric hypothesis, the PUFA molecule act
electrostatically on positive residues of the voltage sensor domain
amongwhich arginine 1 (R1) seems to have a crucial role. Shifting
the R1 from position 362–361 eliminated the enhancing DHA
effect. Moving the charge 2 steps further potentiated the PUFA
effect (Ottosson et al., 2014). In the same line of evidence it was
found that the introduction of a negative charge (substitution to
glutamic acid) in certain positions of the S4 such as A359E, had
an opposite effects on the G(V) curve (smaller hyperpolarizing
shift compared to WT Shaker K+ channels) to the potentiated
effect of arginine (Ottosson et al., 2014). Even more interestingly,
the application of AA+ that was previously shown to decrease
WT Shaker K+ current now it up-regulated A359E channels and
shifted the G(V) curve−8mV strongly indicating an electrostatic
interaction. AA+ did not up-regulated A361E showing again
amino acid side facing dependence. A positive charge at 359
or a negative at 361 promotes channel opening and vice versa
(Ottosson et al., 2014).
According to the structural prediction by Borjesson and
colleagues, Shaker K+ channels, with all S4s in an activated
but non-conducting position, R1 and R2 are exposed to the
extracellular solution with its charges at a distance of 16 Å
away from the approximate PUFA position in the lipid bilayer
adjacent to S3 and S4 (Borjesson and Elinder, 2011). Assuming
that the final position of S4 is according to the KV1.2/2.1 chimera
crystal structure (Long et al., 2007), the charge of R1 moves to
a position only 6 Å away from the PUFA when the channel is
open. A modified Coulomb law was used to estimate the distance
between the PUFA carboxyl charge and the S4 mediated change
in surface as a function of distance from a charge. The predicted 5
mV effect on the first four independent transition steps suggests
that the PUFA charge is located 15.2 Å away from the position
where the positive charges emerge on the channel protein’s
surface. This calculation was based on the assumption that the
channel surface is smooth and that the top S4 charges turn up
on the surface of the channel leaving the inner part of the ion
pore with positive gating charges pairing with negative counter
charges. This is very close to the structural prediction of 16 Å.
The 30 mV effect on the opening step suggests that the PUFA
charge is located 6.3 Å away from R1 in the open state, which
again is almost identical to their prediction from the structural
model.
Collectively the data strongly suggest that the late transitions
(from C2 to O) are the more sensitive steps to DHA. In
the last closed state (C4), R1 and R2 are exposed to the
extracellular solution 16 Å away from the PUFA head group.
In the opening step, R1 moves along the longitudinal axis
of S4 and rotate toward the lipid bilayer, in the vicinity of
the negatively charged bound PUFA (6 Å; Figure 2). DHA
electrostatically affects this rotation promoting Shaker K+
channel activation (Borjesson and Elinder, 2011; Ottosson et al.,
2014).
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Molecular Mechanism of
PUFAs-Dependent Modulation of KCa1.1
Channels
Contrary to the DHA effects on Shaker K+ channels, hKCa1.1
channels do not require voltage sensor activation for the
PUFA effect. DHA augmented single channel open probability
at hyperpolarized potentials where the voltage sensors are
predominantly at rest (Hoshi et al., 2013b). In hKCa1.1 channels,
opening probability at hyperpolarizing potentials is mainly
driven by the opening and closing transitions of the activation
gate located near or within the selectivity filter (Seibold et al.,
2008). The closure of the activation gate controls the deactivation
kinetics and the opening of the gate controls the macroscopic
activation kinetics. DHA did not affect the deactivation kinetics
of hKCa1.1 channels at hyperpolarized potentials, suggesting that
the PUFA accelerates the opening of the activation gate and
increases open probability (Hoshi et al., 2013b).
NEW TARGETS FOR PUFAS ION CHANNEL
MODULATION
Another crucial aspect needed to determine the beneficial effects
of n-3 PUFAs in cardiovascular health is to establish for which
pathologies are n-3 PUFAs truly beneficial, neutral or harmful.
To do so, it is essential to find new molecular targets responsible
for these effects and to analyze how its modulation by PUFAs
can affect the physiology in cardiovascular disease models. In
this section we summarize recent findings on novel K+ channels
targets involved in vascular relaxation, blood pressure lowering,
and prevention of fatal arrhythmias after acute myocardial
infarction (AMI).
Potassium Channels As Targets Involved in
Vascular Relaxation and Blood Pressure
KCa1.1 Channels
In vascular smooth muscle cells (SMC) human KCa1.1 channels
or large conductance Ca2+-activated K+ channels hKCa1.1
channels together with β1 subunits, have been reported to
contribute to the regulation of vascular tone. Activation of
KCa1.1 channels acts to keep the membrane hyperpolarized,
thus generally exerting a negative feedback influence on cellular
excitability (Patterson et al., 2002; Nelson and Bonev, 2004).
Consumption of oily fish high in DHA has been suggested to
decrease blood pressure in some individuals (Ramel et al., 2010;
Saravanan et al., 2010; Liu et al., 2011). Application of DHA
dilates isolated blood vessels (Wang et al., 2011) potentially
by activating KCa1.1 channels (Lai et al., 2009; Wang et al.,
2011). To further examine this hypothesis, Hoshi and colleagues
generated a KCa1.1 channel deficient mice model mKCa1.1−/−,
and compared the modulatory effect of DHA in aortic vascular
SMCs from wild-type (WT) and mKCa1.1−/−mice. Whole-cell
outward currents recorded from dissociated aortic vascular SMCs
from WT mice were enhanced by extracellular application of
DHA but no effect was seen in SMCs from mKCa1.1 deficient
mice. Furthermore, the application of DHA into a central vein
inWTmicemarkedly lowered arterial blood pressure. Consistent
with the idea that DHA exerts its hypotensive action by activating
KCa1.1 channels, injection of DHA into KCa1.1−/− mice had no
effect on blood pressure (Hoshi et al., 2013b). Finally, a bolus
of DHA ethyl ester had no effect on blood pressure of WT or
mKCa1.1 deficient mice. Together, these results confirmed the
blood pressure lowering effect of DHA observed in WT mice
is directly mediated by the activation of mKCa1.1 channels in
vascular SMCs and highlight hKCa1.1as a major target of the
reported PUFA hypotensive effects.
K2P Channels
The two-pore domain potassium channels (K2P) traditionally
viewed as “background” (voltage-independent) K+ channels are
dimmers of K2P subunits, each containing four transmembrane
segments and two-pore-domain arranged in tandem. K2P
channels are mechanosensitive, are active almost instantaneously
at all membrane potentials and exhibit strong outward
rectification (Lesage and Lazdunski, 2000). K2P channels
contribute to the set the restingmembrane potential (Vm) in both
non-excitable and excitable cells. In excitable cells, K2P channels
can contribute to the repolarization as well (MacKenzie et al.,
2015). K2P channels are highly expressed in the lung and cerebral
vasculature (Gardener et al., 2004; Blondeau et al., 2007) where
they have been suggested to participate in the endothelium-
dependent vasorelaxation.
A study by Blondeau et al. (2007) showed that alpha linolenic
acid induced vasodilation of the basilar artery in WT but not
in K2P2.1−/− mice (Blondeau et al., 2007; Garry et al., 2007).
More interestingly, it has been suggested that the expression
level of K2P channels might be altered in pathological conditions
such as pulmonary hypertension (Garry et al., 2007). Pulmonary
hypertension is a pathological condition in which there is an
increase of blood pressure in pulmonary arteries that can lead
hypertrophy of the right ventricle and, finally, heart failure
(Hyvelin et al., 2005; Wilkins, 2012). In a comparative study,
a 4.4-fold higher density of an endogenous mechanogated K+
channel with properties resembling those of K2P2.1 was found
in aortic endothelial cells from spontaneously hypertensive vs.
normotensive Wistar-Kyoto rats (Hoyer et al., 1997). In the
same line of evidence, it was found that K2P6.1−/− knockout
mice had a more depolarized Vm in aortic SMC, and a higher
systemic blood pressure compared to WT mice (Lloyd et al.,
2011). Therefore, it was crucial to determine whether K2P2.1
and/or other closely related PUFAs-activated K2P channels would
play a crucial role in the prevention and or progression of
pulmonary hypertension. In a recent study conducted by Nielsen
et al. (2013), the expression of different K2P channels was studied
under healthy conditions in the murine lung and in a murine
model of pulmonary hypertension induced by hypoxia. In the
lung of healthy mice, high expression of mRNA of K2P2.1
followed by intermediate levels of K2P6.1 and low expression of
K2P4.1, K2P10 were found. Voltage clamp experiments showed
PUFAs-sensitive K2P channels in endothelium of the main
pulmonary artery and of carotid artery. These currents were
blocked by unspecific K2P blockers pimozide and flupentixol.
Current clamp experiments in pulmonary artery endothelial
cells showed that DHA induced a hyperpolarizing shift of
Frontiers in Physiology | www.frontiersin.org 7 November 2016 | Volume 7 | Article 578
Moreno et al. Polyunsaturated Fatty Acids and Kv Channels
the Vm of −28 mV. This shift was reversed by pimozide
suggesting that DHA caused hyperpolarization through PUFAs-
activated K2P channels. DHA activated K2P channels in these cells
inducing hyperpolarization and therefore relaxation. Previous
studies suggested that vasorelaxation induced by PUFAs in
the pulmonary circulation were partially mediated by TEA-
sensitive K+ channels (Morin et al., 2009). Conversely, the study
by Nielsen and colleagues showed no attenuation of DHA-
induced vasorelaxation when TEA-sensitive channels KCa3.1,
KCa2.3, and KCa1.1 channels were inhibited, suggesting that
other mechanisms such as K2P activation, play a role in
DHA-dependent vasorelaxation. Endothelial denudation did
not prevent the DHA effect, indicating that DHA interacts
with K2P channels directly in the SMC layers. However,
specific K2P inhibitors are required to confirm this assumption.
Altered K2P channel expression patterns were observed in
hypertensive animals. K2P6.1 channels were significantly up-
regulated by four-fold in the lungs of chronic hypoxic mice.
The physiological meaning of K2P channel upregulation in
pulmonary hypertension is not fully understood. Although
further experiments are required to clarify this point, this study
reveals K2P channels as potential targets in this condition.
Potassium Channel Targets involved in the
Prevention of Fatal Arrhythmic Events in
the Early Phase of Myocardial Infarction
KATP Channels
Most deaths due to AMI are caused by ischemia-induced
ventricular fibrillation (VF) within the early hours after the
onset of infarction (O’Doherty et al., 1983). The GISSI-
Prevenzione trial on the effects of long term treatment with
n-3 PUFAs demonstrated that these substances reduce sudden
cardiac death after AMI (GISSI-Prevenzione Investigators, 1999).
KATP channels have been suggested to provide cardioprotection
by promoting action potential shortening and decreasing
repolarization dispersion (Chi et al., 1990; Venkatesh et al., 1991).
In 2011, Tsuburaya and colleagues conducted the first in vivo
study to test the potential antiarrhythmic effects of long term
EPA treatment on ischemia-induced VF in pigs (Tsuburaya et al.,
2011). Myocardial infarction was induced in these animals by left
coronary artery occlusion and the electrophysiological outcomes
on action potentials were analyzed. The survival rate was 50%
in the control group vs. 100% in the EPA group. In the control
group, many VF episodes caused by triggered extra systoles were
recorded during ischemia and terminated by current shocks.
Conversely, non-sustained ventricular tachycardia episodes (VT)
were recorded in the EPA group. The occurrence of VT/VF
and the prevalence of pulseless VT/VF was significantly reduced
in the EPA group. After the left coronary occlusion, in the
control group, MAPD90 (monophasic action potential duration
measured at 90% of repolarization) was significantly shortened
at the ischemic region while in the EPA group this shortening
was significantly attenuated. The pretreatment with cromakalim
(KATP channel opener) abolished the inhibitory effects of EPA on
ischemia-induced MAPD90 shortening, VT/VF occurrence and
deteriorated the survival rate during ischemia in the EPA group to
50%. At the molecular level, EPA treatment significantly reduced
cardiac mRNA and protein expression and of Kir6.2 (a major
component of the sarcolemmal KATP channel) and increased that
of the auxiliary SUR2B subunit. Taken together, these findings
indicate that EPA suppressed acute phase fatal ventricular
arrhythmias (15 min after onset). EPA had an inhibitory
effect on ischemia-induced VF in vivo probably mediated by
amelioration of ischemia-induced monophasic action potentials
shortening (Tsuburaya et al., 2011). Nevertheless, patch clamp
studies are needed to demonstrate inhibition of KATP in
cardiomyocytes.
NEW DISCOVERIES IN KV7 FAMILY
The KV7.1 family of voltage-gated K+ channels comprises
KV7.1–KV7.5 channels. In the heart, KV7.1 channels co-assemble
with KCNE1 subunits to give rise to the slowly activating delayed-
rectifier K+ current IKs. This current contributes importantly
to cardiac repolarization particularly during β-AR stimulation
(Sanguinetti et al., 1996; Volders et al., 2003). The other
four components of the KV7 family (KV7.2–KV7.5) are mainly
expressed and studied in the nervous system, although they play
important roles in other tissues as well (i.e., vascular smooth cells,
ear cells, etc.). KV7.2 and KV7.3 are the major components of
the slow voltage-activated M-current. KV7.2/KV7.3 channels are
opened already at rest hence contributing to the Vm of dorsal
root ganglion (DRG) and hippocampal neurons, and regulating
neuronal excitability (Jentsch, 2000; Brown and Passmore, 2009).
PUFAs and Cardiac IKs (KV7.1/KCNE1)
As with many other K+ channels, KV7.1 channels and, therefore,
IKs are modulated by PUFAs. Doolan et al. (2002) demonstrated
that EPA increases the magnitude of the IKs in Xenopus
oocytes. Furthermore, long term PUFA treatment was shown
to enhance IKs in cardiac myocytes from pigs pigs fed on
a PUFA high diet compared to IKs from pigs fed with a
normal diet (Verkerk et al., 2006). However, the molecular
mechanism underlying the PUFAs-dependent modulation of
KV7.1/KCNE1 remained to be elucidated. In 2015, two studies
addressed this question (Liin et al., 2015; Moreno et al.,
2015).
Moreno et al. (2015) analyzed the effects EPA and DHA in
KV7.1/KCNE1 channels expressed on a heterologous expression
system and in IKs in guinea pig myocytes. Two aspects of PUFA-
dependent modulation of ion channels merit particular attention.
(i) Dietary PUFAs incorporate to the cell membrane. Therefore,
PUFAs-dependent modulation of ion channel depend on the way
of administration: acute vs. chronic [see Moreno et al. (2012)
for extensive review]. In fact, Moreno and colleagues reported
that acute but not chronic administration of PUFAs increased the
magnitude of KV7.1/KCNE1 channels and shifted the activation
curve toward opposite directions (leftward and rightward shift
for acute and chronic administration, respectively). In addition,
long-term administration of n-3 PUFAs reduced KV7.1 but not
KCNE1 expression due to increased degradation via proteasome.
The significant decrease in KV7.1 expression level might account
for the lack of current density increase when n-3 PUFAs were
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applied chronically (Moreno et al., 2015). (ii) Direct vs. indirect
effects. As previously mentioned, there were two trends of
opinion to explain the mechanism of action by which PUFAs
modify ion channels: direct interaction vs. alteration of the cell
membrane fluidity. Evidences in favor of both type of modulation
were found simultaneously in the study by Moreno et al. (2015).
Chronic administration of EPA and DHA disrupted lipid rafts
domains where KV7.1 channels are normally found (Balijepalli
et al., 2007) delocalizing KV7.1 in the cell membrane. Lipid
raft disruption can be mimicked within minutes by the acute
application of methyl-β-cyclodextrin (MBCD). The application
of MBCD increased the current magnitude of KV7.1/KCNE1
at potentials positive to +30 mV and shifted the activation
curve toward positive potentials emphasizing the impact of the
membrane environment on channel properties (indirect effect;
Figure 4; Moreno et al., 2015). On the other hand, after lipid
raft disruption with MBCD, acute application of EPA produced
similar effects than those observed in non-cholesterol-depleted
cells: Current density increase and shift of the midpoint in the
hyperpolarizing direction. This fast modulation was explained by
a direct effect on the ion channel of EPA during acute application.
Together these data provided evidence for direct and indirect
PUFA dependent modulation of K+ channels suggesting that
both mechanisms are not mutually exclusive and can happen
simultaneously (Moreno et al., 2015).
The study by Liin et al. (2015) examines the mechanism by
which n-3 PUFAs promote KV7.1 channel opening and how
KCNE1 modulated KV7.1 sensitivity to PUFAs. In addition,
they explored the possibility to develop PUFAs analogs as
drugs to prevent cardiac arrhythmias. Similarly to what was
described for Shaker K+ channels, DHA promotes channel
opening by acting electrostatically on the VSD of KV7.1 channels.
KCNE1 tunes KV7.1 sensitivity to PUFAs by lowering the
local pH in the vicinity of the PUFA head group which
results in DHA protonation. In other words, the PUFA effect
is KCNE1-independent as long as the PUFA is negatively
charged (Liin et al., 2015). This finding raised the possibility
to study the antiarrhythmic potential of n-3 PUFAs analogs as
novel therapeutic agents. In this regard, Liin and colleagues
tested the effects of two PUFAs analogs in two arrhythmia
models: isolated embryonic rat cardiomyocytes and the intact
heart of guinea pig. In isolated embryonic rat cardiomyocytes
(in which IKs but not IKr rapidly activating delayed rectifier
potassium current is expressed) arrhythmia was induced by
applying subsaturating concentrations of chromanol 293B and
the effects of N-arachidonoyl taurine were tested. Chromanol
293B increased action potential duration and led to arrhythmic
firing. The permanently negatively charged N-arachidonoyl-
taurine reversed the effect of chromanol 293B decreasing the
action potential duration (APD) and abolishing the arrhythmic
FIGURE 4 | Effects of EPA in membrane cholesterol-depleted cells with methyl-β-cyclodextrin (MβCD). (A) Current records obtained from the same cell and
generated by KV7.1-KCNE1 channels in control, after perfusion with MβCD, with EPA and after washout the cells with EPA-free external solution. (B) Current-voltage
relationships under all conditions shown in (A). (C) Plot showing the voltage dependence of the MβCD and EPA effects (D) Activation curves and (E) normalized
activation curves. Moreno et al. (2015).
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firing. The effects of docosahexaenoyl glycine were tested on the
intact heart of guinea pig (DHA-Gly has a lower pKa than DHA
and therefore is negatively charged at physiological pH even in
the presence of KCNE1). To mimic the long QT (syndrome
characterized by a long interval between the Q and the T
waves of the ECG) setting in this model (APD duration and
QT prolongation), the E4031 IKr blocker was applied. Perfusion
of the guinea pig heart with 10 µM DHA-Gly reversed the
effects of E4031 restoring QT interval duration (Liin et al., 2015)
demonstrating their antiarrhythmic potential.
Concerning the PUFAs antiarrhythmic mechanism, minor
discrepancies can be found through the literature. Overall,
in vitro and in vivo experiments and clinical trials support an
antiarrhythmic effect of PUFAs. Liin and colleagues claim that
the antiarrhythmic effects of DHA cannot be due to effects on
IKs gating because at physiological pH 7.4, KCNE promotes
DHA protonation making DHA ineffective (Liin et al., 2015).
Instead they propose that the antiarrhythmic effect of PUFAs
in the heart is due to the inhibition of INa or ICaL (Leaf
et al., 2003, 2005; Danthi et al., 2005; Boland and Drzewiecki,
2008). However, we found that both EPA and DHA increase
IKs in guinea pig cardiomyocytes and shifted the G(V) curve
toward the hyperpolarizing direction of IKs expressed in COS7
cells. Furthermore, action potential simulations showed that the
increase of IKs induced by acute administration of PUFAs could
play a relevant role in action potential shortening when other
repolarizing current for instance IKr, are compromised. On the
other hand, chronic exposure to PUFAs does not affect APD so
that the protective role seems lost in this condition.
PUFAs and Neuronal M-Current
It has been reported that PUFAs increase both seizure and pain
thresholds (Voskuyl et al., 1998; Xiao and Li, 1999; Taha et al.,
2010; Bandero et al., 2013) in rats and mice, and reduce neuronal
excitability in vitro (Xiao and Li, 1999; Young et al., 2000).
As it was shown for the heart, the modulation of neuronal
excitability by PUFAs is mediated by effects on ion channels
crucial for neuronal excitability (Boland and Drzewiecki, 2008).
PUFAs have been suggested to increase the M-current but their
effects are complex and not completely understood. In a recent
paper, it was shown again that only negatively charged n-3
PUFAs such as DHA, EPA, ALA, can quickly shift the G(V)
curve of KV7.2/KV7.3 channels expressed on Xenopus oocytes
toward more negative voltages facilitating channel opening (Liin
et al., 2016; Valenzuela, 2016). More importantly, the anti-
excitable effects of PUFAs on the neuronal M-current were
studied in dorsal root ganglions from mice. Addition of DHA
to dorsal root ganglion neurons hyperpolarized the Vm (by
−2.4mV) increasing the threshold current required to evoke
action potentials. Since these effects were reverted by the M-
current blocker XE991, the reduced neuronal excitability was
attributed to the PUFA mediated augmentation of M-current
(Liin et al., 2016). In the same line of evidence, computer
simulations predict that equivalent changes around 1–5 mV in
the Vm of neurons and in the voltage-dependence of ion channel
activation is sufficient to decrease neuronal excitability and
prevent epileptic episodes (Tigerholm et al., 2012). In summary,
all these results suggest that PUFAs can be used as a blueprint for
rational drug design of new M-currents activators more selective
and efficient for the treatment of neurological disorders such as
epilepsy and pain.
CONCLUDING REMARKS
From 1990’s we know that PUFAs produce diverse effects on ion
channels that might be beneficial for health. The mechanism of
action initially proposed by the Elinder’s group: The lipoelectric
hypothesis (the lipid bilayer or bilayer/channel interface close
to the S3–S4 segment) from where they act electrostatically on
the voltage sensor and thereby change the voltage dependence of
the channel. The modulation of potassium channels by PUFAs
is channel specific, as indicated by the identification of two
PUFAs binding sites in different potassium channels families.
Besides the gating modulation of ion channels different studies
have demonstrated that PUFAs can modulate differentially ion
channels for instance through the modulation of the biophysics
of the lipid bilayer, by targeting the channels to different areas
of the cell membrane (i.e., lipid rafts) and even modifying the
gene expression. Finally, other ion channels such as KCa1.1,
KATP, and K2P have been recently reported as sensitive to the
effects of PUFAs. Since these potassium channels are present in
the cardiovascular and in the nervous systems, PUFAs might
play an important role in the control of blood pressure, cardiac
arrhythmias, and neurological disorders.
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